Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia
PHASE2
This phase II trial studies how well a dose adjusted regimen consisting of ...
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
PHASE1
This phase IB trial studies the feasibility of using a functional laborator...
Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma
PHASE1
This pilot phase I trial studies the side effects of pembrolizumab and comb...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium